Matthew Nelson
Principal investigator.
Medtech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2023First federal award
$1.8MFederal grants as PI3 awards
1Patents grantedLatest May 6, 2025
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
3 awards · $1.8M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jun 5, 2025 | NSF | SBIR Phase II SBIR Phase II: Enrichment of Cancer DNA for Improved Cancer Diagnostics from Blood | $1.3M | NEXGEN CANCER DETECTION LLC |
| Aug 1, 2023 | NSF | SBIR Phase I SBIR Phase I:Enrichment of Cancer DNA for Improved Cancer Diagnostics from Blood | $275K | NEXGEN CANCER DETECTION LLC |
| Jul 25, 2023 | NSF | SBIR Phase I SBIR Phase I: Enrichment of Cancer DNA for Improved Cancer Diagnostics from Blood | $275K | NEXGEN CANCER DETECTION LLC |
2 patents as inventor
- US 12291744NEXGEN CANCER DETECTION LLCMay 6, 2025
- US NEXGEN CANCER DETECTION LLC—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#1,324
Awards as PI#927
Patents#284
Companies
- NEXGEN CANCER DETECTION LLCLinked by awards · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.